Achieving Excellence in Continuous Manufacturing: Using Process Models for Process Development and Understanding Process Dynamics

Similar documents
Scientific Considerations for Continuous Manufacturing Processes

Current FDA Perspective for Continuous Manufacturing

Variation and Risk Analysis in Tablet Press Control for Continuous Manufacturing of Solid Dosage via Direct Compaction

Fault tolerant control for safe plant operation. November 10, 2016

COMBINED FEEDFORWARD/FEEDBACK CONTROL OF AN INTEGRATED CONTINUOUS GRANULATION PROCESS

An integrated multi-layer approach to control strategy for continuous drug product manufacture

Enhancing Product Quality through CM An Industry Perspective for Transitioning CM from Technology Evaluation to a Default Manufacturing Platform

Optimization of a Continuous Wet Granulation Process by Understanding Granule Properties

Scientific and Regulatory Considerations for Continuous Manufacturing Implementation for Drug Product

Regulatory Assessment

Continuous Manufacturing: An Industry View

PMDA Views on Applying Continuous Manufacturing to Pharmaceutical Products for Industry (provisional draft)

A Risk-based Approach to Development and Manufacture of a New Chemical Entity using PCMM

Continuous Manufacturing

Quality by Design, Revolution or Evolution? Wim Oostra

LABRAM Characterization Studies

PAT for the On-line Characterization of Continuous Manufacturing Systems

Benefits and Opportunities of Continuous Manufacturing

Content PART I: ANDA Roadmap PART II: Understanding of CPPs & CQAs PART III: Scale-Up and Technology Transfer PART IV: Process Validation & Sampling 2

PAT for the On-line Characterization of Continuous Manufacturing Systems

Tablet formulation design spaces for direct compression and roller compaction. QbD in Pharmaceutical Development: processes

Scientific Considerations for Continuous API Manufacturing

Better wet granulation: development, scale-up and manufacture

FDA Perspective on Continuous Manufacturing

Applied Process Understanding in Drug Product Development

Quality by Design (QbD)

Scientific and Regulatory challenges in Quality by Design (QbD) submissions

Roller Compaction: New trends, challenges and solutions

PAT in Action: A Lifecycle Approach to Applied Process Understanding to set meaningful process and product specifications October, Heidelberg, Germany

The Value of High-Functionality Excipients in Continuous Manufacturing Tony Carpanzano, B.S., R. Ph. Director, R&D JRS Pharma, LP, Patterson, NY

Roller compactors for the pharmaceutical industry. BT 120 Pharma WP 120 Pharma WP 150 Pharma WP 200 Pharma

How to Identify Critical Quality Attributes and Critical Process Parameters

Quality by Design and Expertise: Accelerating time to market of complex oral solid dosage forms

NIRS, PAT, RTR testing EU experience and regulatory perspective

Inaugural-Dissertation. zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf

Model-based design of a plant-wide control strategy for a continuous pharmaceutical plant

White Paper 9. HSWG-Brivanib Alaninate: DFF Sensor Identifies Optimal Formulation, Determines Granulation End-Point, and Enables Scale Up

Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL

Maximizing Roller Compaction Benefits with Proper Excipient Selection

The Use of Stratified Sampling of Blend and Dosage Units to Demonstrate Adequacy of Mix for Powder Blends 1

for the Batch Manufacture

Regulatory and Quality Considerations for Continuous Manufacturing

Seamless Integration of a Semi- Continuous Coating Process into Existing Solid Dosage Production

Pharmaceutical control strategy what does it mean and how do we apply? Martin Warman, Martin Warman Consultancy Ltd

Manufacturing Technology Committee Risk Management Working Group Risk Management Case Studies. Case No. RMWG-07. Space

Inspection. Implementation of ICH Q8, Q9, Q10

Continuous Manufacturing. Combined approved technologies swiss made. Prospekt Nr. 655

Mitigating Commercial Risks in Continuous Manufacturing Drug Product

Engineering in Chemical and Pharmaceutical Processes. Compressing the powder between two surfaces

ConsiGma. A platform for Continuous Solid Dosage manufacturing enabling Quality by Design and Lean Manufacturing O. GOLDSTEIN

QbD implementation in Generic Industry: Overview and Case-Study

Stage 3 - Process Validation: Measuring what matters

Continuous Processing. MODCOS for Continuous Oral Solid Dosage Production Textmasterformat in Mastervorlage eingeben

Achieving Quality Beyond Compliance Through Continuous Manufacturing

Taking mechanistic models from R&D and Engineering into Operations

Fine dosing The fine art of fine dosing

Quality by Design for Drug Products. Dr. Lorenz Liesum Global Technical Operation, Novartis Swiss Association for Quality Meeting , Olten

Sarang Oka ALL RIGHTS RESERVED

Available online at ScienceDirect. Procedia Engineering 102 (2015 )

CHALLENGES & OPPORTUNITIES OF ICHQ8 (PHARMACEUTICAL DEVELOPMENT) AN INDUSTRY PERSPECTIVE

Fine dosing The fine art of fine dosing

Microcrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate

Implementing Continuous Pharmaceutical Manufacturing: An FDA Perspective

Best Practices for Effective Tablet Lubrication

coating Layering an API onto tablets using a perforated-drum coater: A case study ACG Pharma Technologies

Guidance for Industry

TECHNICAL AND REGULATORY CONSIDERATIONS FOR PHARMACEUTICAL PRODUCT LIFECYCLE MANAGEMENT Q12

Continuous Manufacturing Critical Steps and

AdaptDose, an innovative platform that reduces product development time and costs by 30% or more

A Framework and Case Study for Implementing the New Process Validation Guidance

R&D TO PRODUCT: HOW TO REDUCE COSTLY SCALE-UP PROBLEMS

Title Freeze-Drying cycle monitoring Problem Statement Approach Result Impact

BMS Experience with the FDA-EMA QbD/PAT Joint Pilot Ambarish K. Singh, PhD Director, Global Regulatory Sciences-CMC Bristol-Myers Squibb Company

2nd FDA/PQRI Conference on Advancing Product Quality

TABLETABILITY, COMPACTABILITY, AND COMPRESSIBILTY: WHAT S THE DIFFERENCE?

Control Strategy. Implementation of ICH Q8, Q9, Q10

PHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Experimental Methods

REAL-TIME OPTIMIZING CONTROL OF A CLASS OF CRUDE OIL BLENDING OPERATIONS

Implementing Quality by Design Principles and Concepts to Drug Delivery and Formulation Development. S Betterman 15Apr2015

Dynamic degrees of freedom for tighter bottleneck control

INNOVATION IN PHARMACEUTICAL MANUFACTURING OF SOLID DOSAGE FORMS VIA CONTINUOUS WET GRANULATION

Oral Dosage Formulation Development

Application of PAT for Tablet Analysis. Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013

Simulation of a Fluidized Bed Spray Granulation Pilot Plant GF/ProCell 25 with the Flowsheet-Simulation Software SolidSim

Continuous granulation of pharmaceutical powder using a twin screw granulator

University of Sulaimani College of Pharmacy Dept. of Pharmaceutics 5 th stage Second Semester

The Value of Powder Testing. freemantechnology

Novartis E2E CM case study

PHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Experimental Methods

1 State of Control. 1. Continuous Manufacturing. State of Control ICH Q10. Steady State 2. ICH Q10. State of Control. State of Control ICH Q10

Streamlined Manufacture of Modified Release Matrix Tablets via Direct Compression. Katie Hewlett, Dow Gus LaBella, Colorcon

Aspects of Screw Design for Wet Granulation Extrusion

ICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management - Annexes

Approaches to regulatory engagement and filing for continuous manufacturing

MEETING YOUR CHALLENGES TODAY AND TOMORROW. Avicel PH BINDERS

Identification of CPPs based on CQAs & Mechanistic Process & Product Understanding: A Case Study

Method Development and Validation for Online UV-Dissolution Methods Using Fiber-Optic Technology

Learning from the Application of Real-Time Analytics for Process Understanding, Control and Real-Time Release Testing

Needs and Opportunities for Continuous Manufacturing (industrial perspective)

Transcription:

Achieving Excellence in Continuous Manufacturing: Using Process Models for Process Development and Understanding Process Dynamics By Fernando Muzzio, Marianthi Ierapetritou, Rohit Ramachandran, Amanda Rogers, Ravendra Singh, and William Engisch Presented at the FDA/PQRI symposium September 2014

Overview Flowsheet models Applications to process design Applications to risk assessment and validation Applications to process control Way forward HME, capsule filling, predictive material property databases, and real time optimization

What is flowsheet modeling? Flowsheet modeling uses differential, algebraic and integral equations to describe the physics and dynamics of processing unit operations Unit operations can be combined in sequence to represent a complete manufacturing process this is a flowsheet model Process responses calculated in one unit become inputs to the next unit Sensors and control loops can be included to describe the dynamics of the entire system FEEDERS: Model: Delay Differential Equation DIRECT COMPACTION Hopper: Model: Delay Differential Equation Powder properties, Flowrate set point rpm, tooling Powder properties, Flowrate Blend Powder properties, Flowrate in geometry Blend powder properties, Flowrate out, Mass holdup MIXER: Model: Residence time distribution (RTD) rpm, Powder geometry properties, Flowrate in Blend powder properties, Flowrate out Tablet press: Model: RTD, Heckel or Kawakita compression equation Blend powder properties, Flowrate in feed frame speed, compression force, fill depth tablet production rate, tablet weight, tablet hardness, disso.

Why flowsheet modeling? Flowsheet models can be applied to pharmaceutical processes in order to: Conduct preliminary design evaluation Identify potential bottlenecks Compare control strategies Identify potential critical process parameters Explore design space Enhance process understanding

rpm Building a unit operation model Each unit operation can be described by a system of equations that relates process inputs to process outputs The model should represent the major phenomena associated with the transformation of inputs to outputs. For example: A blender model should relate blend homogeneity (RSD, segregation intensity) to relevant operating parameters like rpm and raw material flowrates A tablet press model should incorporate compression equations relating inlet bulk density to tablet porosity via applied compression force Raw material flowrates for each component in blend RSD, Flowrate out Inlet ρ bulk Compression force Tablet porosity

Building a unit operation model Unit operation models should also account for process dynamics. For instance: The dynamic response of the system to a change in operating conditions should be captured through transfer functions Residence time in each unit operation should be considered so that the response of the system to transient disturbances can be accurately captured y set τ time constant y flowrate y set flowrate set point change y set Material in at t=t 0 τ - mean residence time Material out at t=t 0 + τ dy y y dt set y(t) time

Continuous tablet manufacturing pilot-plant Sponsored by JnJ Direct Wet Dry Compaction Granulation Enable: Continuous FLEXIBLE multipurpose platform Singh, R., Boukouvala, F., Jayjock, E., Ramachandran, R. Ierapetritou, M., Muzzio, F. (2012). Flexible Multipurpose Continuous Processing. PharmPro Magazine, 28 June, 2012,

Validation of Continuous Processes What does validation mean for a continuous process? Traceability of materials through process Understanding of process dynamics Identification of critical parameters Design and implementation of control strategies to ensure product quality How can flowsheet modeling contribute to continuous process validation? Understand variability propagation Identify potential CPPs and control variables using uncertainty and sensitivity analysis Predict traceability of raw materials through a system Determine design space and evaluate process robustness using Flexibility and Feasibility Analysis 9

Disturbance Propagation in Continuous Systems Continuous manufacturing processes are integrated systems Interconnected series of unit operations Transient disturbances propagate from one unit operation to the next Downstream processing may attenuate or filter out variability Poorly designed feedback controls can AMPLIFY perturbations Dynamic simulation and uncertainty analysis can be used to understand propagation of variability in continuous systems 10

Tracking response to step changes Simulate step changes in mixer RPM Tracking variability in RSD in response to changes in mixer RPM Monitor hopper fill-level to avoid overfilling RSD max 11

Evaluating response to transient disturbances An unavoidable perturbation in a continuous manufacturing process is a feeder refill This disturbance is propagated to downstream unit operations - distribution changes due to RTD in the system 12

Propagation of uncertainty in granulation flowsheet- uncertain inputs Density fluctuates Granulation model parameters fluctuate Mass flow rate fluctuates gsolids template is used for this case study of a 3 component mixture being granulated and milled Significant inputs are chosen: Material properties (bulk densities) API flowrate Breakage parameters in milling These inputs are sampled according to known distributions and their effects on process outcomes are observed 13

Group Uncertainty propagation-direct Compaction case study Total number of 2048 scenarios were simulated in parallel (gproms) and analyzed in SIMLAB Example of questions we aim to answer: Does the uncertainty in the feed flow rate cause variability at the outlet of the blender? 14

Sensitivity Analysis Process of attributing variance in process responses to sources of variability in the process and/or model Local one at a time variation of parameters Global simultaneous variation of parameters Appropriate to complex systems with parameter interactions Sensitivity metrics indicate the magnitude of the effect of a process variable on a particular process response Applications for pharmaceutical process development Identification of critical process parameters Potential control variables and development of control strategies 15

Sensitivity Analysis Case Study Direct Compaction Process 22 factors 19 responses Which factors contribute most significantly to variability in process outcomes? Rogers, et al. Ind Eng Chem Res 2013, doi. 131015102838009. 16

Partial Rank Correlation Coefficient Eliminate parameters that are less significant for subsequent analysis For variance-based methods, the number of samples required to estimate indices increases with the number of inputs considered Parameters related to lubricant properties or feeding Univariate input-response relationships FF rotation rate Tablet press compression force Hopper aperture Identify potential critical parameters Material properties (API, Excipient) Feeder parameters Screw rpms Feeder gain parameter 17

Conclusions for Direct Compaction Case Study Potential CPPs API and Excipient physical properties including d50 and bulk density Interaction between API and Excipient properties is also significant consideration when determining design space Feeder tooling and sizing interacts with operating parameters Important to consider design variables when optimizing process operations Potential Manipulated Variables API and Excipient feeder screw rpms Mixer rpm interacts with API and excipient feed rates Applications Quality risk assessment Control strategy design Design space determination 18

Direct compaction - traceability Input: Total throughput, formulation, feeder hopper sizes and refill strategy: Individual feeder rpm Hopper fill level time of refill causes peak in feedrate Discard tablets during: [0-800], [5000-5250], [9400-10000], [13900-14400] and [18000-19500] seconds 96% Avicel, 3% Acetaminophen, 1% MgSt, 100 kg/hr, refill level 20% 19

The Challenge of defining a Batch Material traceability in a batch process is wellunderstood. Continuous still has a gap between understanding and regulatory acceptance. Batch Processing Batch 1 Batch 2 Batch 3 Batch 4 Batch 5 Continuous Processing Batch 1 Batch 2 Batch 3 Batch 4

RTD of Each Unit Operation

Identifying sources of Downspout Accumulation Feeder Bearding Feeder Fluctuations Disturbances (Feeder hopper refill) variability Refill @ 20%

Detect and Trace Disturbances 0.25 g Pulse 30 kg/hr 6% API Blender: MRT: 41.6s StdDev: 12s

Determine System Robustness 1 g Pulse 30 kg/hr 6% API Blender: MRT: 41.6s StdDev: 12s

Reconfigure Blender to increase backmixing 1 g Pulse 30 kg/hr 6% API Blender: MRT: 71.7s StdDev: 24.9s

Determining Adequate PAT Sensor Frequency t m 2 0 te( t) dt 0 2 ( t t ) E( t) dt m Mean Residence Time: 71.7s Sample Time Interval: 8.3s Sensor at least 3-5 times faster than standard deviation should have decent resolution allowing for detection of pulse variability. Standard Deviation: 24.9s

Introduction to process control Why needed? 1. To achieve the desired predefined end product quality 2. To manufacture the product safely 3. To satisfied the flexible market demands 4. To reduce the manufacturing expenses (e.g. labor cost) 5. To assure consistent manufacturing of desired quality product

Process dynamics Step change u(t) Process dynamics 1 t Process? Process inputs example: Feeder screw rotational speed. Blender RPM. Feed frame speed. Blend density. Material properties. Product quality assurance: Drug concentration? RSD? Tablet weight? Tablet hardness? Tablet dissolution?

Advanced supervisory control system Control variables API composition Powder level Tablet weight Tablet hardness D-RTO

Way forward Expand model library More models, better models Feeders, hoppers, coating pans, granulators More methods for designing, optimizing, controlling, validating, assessing risk More processes HME, capsule filling, biologicals Predictive libraries of material properties for formulation design Two way communication between the process and the model to enable real time optimization